Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: NoneCreation date: 2018-06-28 (7 years)Status: ActiveBusiness sector: Fonds de placement et entités financières similairesLocation: PARIS (75016), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
BIO CAPITAL : revenue, balance sheet and financial ratios
BIO CAPITAL is a French company
founded 7 years ago,
specialized in the sector Fonds de placement et entités financières similaires.
Based in PARIS (75016),
this company of category PME
shows in 2020 a net income negative of -354 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
In 2020, BIO CAPITAL records a net loss of 354 k€. This deficit will reduce equity on the balance sheet.
EBITDA (2020)
?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity
-141 €
EBIT (2020)
?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals
-141 €
Net income (2020)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
-353 840 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at -111%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -882%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2020)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
-111.34%
Financial autonomy (2020)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
-881.818%
Repayment capacity (2020)
?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent 3-5 years : Fair > 5 years : Warning
-0.766
Solvency indicators evolution BIO CAPITAL
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2019
2020
Debt ratio
0.0
-111.34
Financial autonomy
100.0
-881.818
Repayment capacity
None
-0.766
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
-111.342020
2019
2020
Q1: 0.01
Med: 10.43
Q3: 82.59
Excellent
In 2020, the debt ratio of BIO CAPITAL (-111.34) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
-881.82%2020
2019
2020
Q1: 16.33%
Med: 62.48%
Q3: 90.92%
Average-50 pts over 2 years
In 2020, the financial autonomy of BIO CAPITAL (-881.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
-0.77 years2020
2020
Q1: -0.03 years
Med: 0.01 years
Q3: 3.79 years
Excellent
In 2020, the repayment capacity of BIO CAPITAL (-0.77) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
Interest coverage (2020)
?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable 1.5-3 : Acceptable < 1.5 : Risk
-250850.355
Liquidity indicators evolution BIO CAPITAL
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2019
2020
Liquidity ratio
None
None
Interest coverage
None
-250850.355
Sector positioning
Interest coverage
-250850.36x2020
2020
Q1: -63.5x
Med: 0.0x
Q3: 0.0x
Watch
In 2020, the interest coverage of BIO CAPITAL (-250850.4x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Positioning of BIO CAPITAL in its sector
Comparison with sector Fonds de placement et entités financières similaires
Similar companies (Fonds de placement et entités financières similaires)
Compare BIO CAPITAL with other companies in the same sector:
The revenue of BIO CAPITAL is not publicly disclosed (confidential accounts filed with INPI).
Is BIO CAPITAL profitable?
BIO CAPITAL recorded a net loss in 2020.
Where is the headquarters of BIO CAPITAL ?
The headquarters of BIO CAPITAL is located in PARIS (75016), in the department Paris.
Where to find the tax return of BIO CAPITAL ?
The tax return of BIO CAPITAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does BIO CAPITAL operate?
BIO CAPITAL operates in the sector Fonds de placement et entités financières similaires (NAF code 64.30Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart